Nurix Therapeutics, Inc. Common stock (NASDAQ: NRIX) last traded at $23.67, up 6.96% on the session. The quote above updates while this page is open; the figures below are drawn from Nurix Therapeutics, Inc. Common stock’s own filings and are restated only when a new one is published.
Nurix Therapeutics, Inc. Common stock trades on NASDAQ under the ticker NRIX. Its market capitalisation is $2.59 billion.
Valuation measures for Nurix Therapeutics, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.59B |
|---|---|
| Enterprise value | $2.09B |
| P/E ratio | 10.29 |
| Price / sales | 3.68 |
| Price / book | 2.67 |
| Beta | 1.22 |
Trailing-twelve-month figures tagged in Nurix Therapeutics, Inc. Common stock's XBRL filings with the SEC.
| Revenue (TTM) | $701.94M |
|---|---|
| Net income (TTM) | $294.88M |
| EPS (TTM) | $2.30 |
| Operating margin | 41.27% |
| Return on equity | 30.45% |
| Cash | $720.24M |
Range and volume for NRIX over the past 52 weeks.
| 52-week high | $28.23 |
|---|---|
| 52-week low | $9.18 |
| Volume | 3.82M |
| Average volume | 1.39M |
| Previous close | $22.13 |
Dividend history for Nurix Therapeutics, Inc. Common stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
| Payout ratio | 0.00% |
Invest a chosen dollar amount in Nurix Therapeutics, Inc. Common stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NRIX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.